Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT06586450
Unknown Not applicable

Effect of Low Level Laser Versus Interferential Current on Postmenopausal Low Back Pain

NCT06586450 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-09-10
Last updated
2024-09-19

Condition(s) studied

Low Back Pain

Investigational drug(s) / intervention(s)

Low level laser therapyInterferential currentCore stability exercise

Low level laser therapy: The participants will receive Low Level Laser on lumbo-pelvic region for 20 min/sessions,3 sessions / week for 12 weeks, with the following parameters: Wavelength: 808 nm, continuous mode, Output power: 160 mw, Penetration depth: 4 cm, Power density:0.16 J/cm2.

Interferential current: All participants will receive interferential current on lumbopelvic region ( quadripolar technique) for 25 min/session, 3 sessions/week for 12 weeks, with the following parameters: carrier frequency of 4 KHZ and sweep frequency 95 HZ, intensity based on patient's tolerance without muscle contraction.

Core stability exercise: The participants will perform core stability exercises for 15 min 3 time/week in the form of Prone Gluteal Squeezes, Pelvic Bridging, Curl Up Exercise, and Double Knee to Chest Stretching Exercises.

Study summary

This study will be conducted to compare the effect of low-level laser and interferential current on postmenopausal low back pain.

Eligibility

Sex
FEMALE
Min age
50 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: • Sixty postmenopausal women (at least one year after stoppage menses). * Their age will be ranged from 50 to 60 years. * Their body mass index (BMI) will be less than 30 kg/m2. * All of them suffer from chronic low back pain (at least 3 months). * The score of pain will be 2 or more according to visual analogue scale (VAS). Exclusion Criteria: * Spinal fracture or any other neurological disorder. * Lumbar disc herniation, degenerative joint diseases, or spondylolisthesis. * BMI\>30 kg/m2 * Gynecological Diseases as Chronic pelvic pain or genital prolapse.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ola Saad El Naggar Alexandria Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06586450 on ClinicalTrials.gov ↗ ← All trials in Egypt